Search research articles
Contact Us
Filters
Showing results (21-30 of 138) with videos related to
Page
of 14
Sort By:
Clinical, Cosmetic and Investigational Dermatology
|
March 24, 2025
Hidradenitis Suppurativa Cancer Risk: A Review of the Literature
Fabrizio Martora, Nello Tommasino, Teresa Battista, et al.
The Journal of Dermatological Treatment
|
January 31, 2022
Guselkumab is efficacious and safe in psoriasis patients who failed anti-IL17: a 52-week real-life study
Matteo Megna, Luca Potestio, Angelo Ruggiero, et al.
Italian Journal of Dermatology and Venereology
|
March 11, 2022
The effects of dupilumab treatment on general health-related work productivity of adult atopic patients
Maddalena Napolitano, Gabriella Fabbrocini, Mariateresa Nocerino, et al.
Psoriasis (Auckland, N.Z.)
|
May 11, 2023
Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature
Luca Potestio, Angelo Ruggiero, Gabriella Fabbrocini, et al.
Clinical and Experimental Dermatology
|
October 8, 2025
The Use of Dupilumab in Difficult-To-Treat Areas of Atopic Dermatitis: Lessons from Real-Life
Michela D'Agostino, Luca Potestio, Cataldo Patruno, et al.
Clinical, Cosmetic and Investigational Dermatology
|
July 31, 2023
Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments
Teresa Battista, Massimiliano Scalvenzi, Fabrizio Martora, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
August 19, 2022
Abrocitinib in atopic dermatitis: review of the current literature and clinical trials
Maddalena Napolitano, Luigi Fornaro, Luca Potestio, et al.
Italian Journal of Dermatology and Venereology
|
January 18, 2023
Assessment of the efficacy, skin acceptability and cosmetic quality of an adjuvant cream based on 40% urea and amino-inositol in the treatment of mild psoriasis
Matteo Megna, Luca Potestio, Lucia Genco, et al.
Dermatologic Therapy
|
June 28, 2022
Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single-center retrospective study in a real-life setting
Matteo Megna, Luca Potestio, Elisa Camela, et al.
Psoriasis (Auckland, N.Z.)
|
June 16, 2022
Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge
Angelo Ruggiero, Luca Potestio, Elisa Camela, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 138) with videos related to
Sort By:
Page
of 14
Clinical, Cosmetic and Investigational Dermatology
|
March 24, 2025
Hidradenitis Suppurativa Cancer Risk: A Review of the Literature
Fabrizio Martora, Nello Tommasino, Teresa Battista, et al.
The Journal of Dermatological Treatment
|
January 31, 2022
Guselkumab is efficacious and safe in psoriasis patients who failed anti-IL17: a 52-week real-life study
Matteo Megna, Luca Potestio, Angelo Ruggiero, et al.
Italian Journal of Dermatology and Venereology
|
March 11, 2022
The effects of dupilumab treatment on general health-related work productivity of adult atopic patients
Maddalena Napolitano, Gabriella Fabbrocini, Mariateresa Nocerino, et al.
Psoriasis (Auckland, N.Z.)
|
May 11, 2023
Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature
Luca Potestio, Angelo Ruggiero, Gabriella Fabbrocini, et al.
Clinical and Experimental Dermatology
|
October 8, 2025
The Use of Dupilumab in Difficult-To-Treat Areas of Atopic Dermatitis: Lessons from Real-Life
Michela D'Agostino, Luca Potestio, Cataldo Patruno, et al.
Clinical, Cosmetic and Investigational Dermatology
|
July 31, 2023
Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments
Teresa Battista, Massimiliano Scalvenzi, Fabrizio Martora, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
August 19, 2022
Abrocitinib in atopic dermatitis: review of the current literature and clinical trials
Maddalena Napolitano, Luigi Fornaro, Luca Potestio, et al.
Italian Journal of Dermatology and Venereology
|
January 18, 2023
Assessment of the efficacy, skin acceptability and cosmetic quality of an adjuvant cream based on 40% urea and amino-inositol in the treatment of mild psoriasis
Matteo Megna, Luca Potestio, Lucia Genco, et al.
Dermatologic Therapy
|
June 28, 2022
Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single-center retrospective study in a real-life setting
Matteo Megna, Luca Potestio, Elisa Camela, et al.
Psoriasis (Auckland, N.Z.)
|
June 16, 2022
Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge
Angelo Ruggiero, Luca Potestio, Elisa Camela, et al.
Page
of 14